MRSA pneumonia is highly antibiotic resistant and most common in patients 65 years or older. Researchers evaluated 38 patients treated with CPT-F. Twenty of these patients were failing standard ...

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs ...

A protein that gives fleas their bounce has been used to boot out bacteria cells, with lab results demonstrating the material ...

A research team affiliated with UNIST has unveiled a novel extracorporeal blood purification technology that captures and ...

Basilea Pharmaceutica announces commercial availability of antibiotic Zevtera in United States: Allschwil, Switzerland Wednesday, May 21, 2025, 11:00 Hrs [IST] Basilea Pharmaceuti ...

After years of working with less-invasive resurfacing treatments, specialists return to laser procedures that require longer ...

Armata Pharmaceuticals has posted early validation of its phage platform. The phase 1b/2a trial linked a bacteriophage ...

Particularly in hospital settings, nurses must be knowledgeable about the epidemiology of MRSA to prevent its spread. The hardy S. aureus bacterium has developed resistance to every antibiotic in ...

The penicillin market thrives on its enduring efficacy and affordability in treating bacterial infections, particularly in ...

aureus (MRSA). The US accounts for 80% to 90% of the total market for anti-MRSA antibiotics, so FDA approval is key to growing ceftobiprole’s revenues, according to analysts. In 2023 ...

Merab Dvalishvili has built an impressive name for himself as the bantamweight champion since winning the belt when he ...